Dynakin now a part of CTI. M&S group.

CTI Clinical Trial and Consulting Services (CTI) is a global, privately held, full-service contract research organization that specializes in working on life-changing therapies in chronically and critically ill patient populations. Modeling & Simulation group within CTI is specialized in Model Informed Drug Development (MIDD). CTI drives the shortest road to your drug development success, leveraging state-of-the-art Industry and regulatory standard pharmacometric methods to maximize efficiency and minimize risk and costs in development.The company has extensive knowledge in performing and in accompanying partners and clients applying PK/PD Modeling and Simulation tools through the R&D for drug development from pre-clinical, FTIM, and Phase I up to Phase III and IV clinical trials.Another field of applied expertise of these Modeling and Simulation tools are special populations and trial design and execution in these, including presentation of the first pediatric investigation plan (PIP) to the EMA.Whether you are working on a new chemical entity, a drug repurposing, or a complex generic, we invite you to contact us to find out how we can bring your project to success.